Veru (VERU) Change in Cash (2010 - 2026)
Veru (VERU) posted quarterly Change in Cash of -$5.4 million for Q1 2026, up 18.12% year-over-year from -$4.6 million in Q1 2025, and down 131.37% quarter-over-quarter from $17.2 million in Q4 2025.
Veru (VERU) Change in Cash (2010 - 2026) Analysis & Trends
Veru (VERU) has reported Change in Cash for 17 consecutive years, with -$5.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 18.12% year-over-year to -$5.4 million; the TTM figure through Mar 2026 stood at $7.6 million (up 151.49% YoY), while the FY2025 annual figure was -$9.1 million, down 159.66% from the prior year.
- Change in Cash fell to -$5.4 million in Q1 2026 per VERU's latest filing, from $17.2 million in the prior quarter.
- Across five years, Change in Cash topped out at $31.0 million in Q4 2023 and bottomed at -$33.3 million in Q4 2022.
- Historically, Change in Cash has averaged -$5.2 million across 5 years, with a median of -$5.6 million in 2024.
- Annual changes were most pronounced in 2022 — Change in Cash tumbled 2456.39% — and 2025, when it soared 917.13%.
- Veru's Change in Cash stood at -$33.3 million in 2022, then soared by 193.06% to $31.0 million in 2023, then sank by 94.54% to $1.7 million in 2024, then jumped by 917.13% to $17.2 million in 2025, then sank by 131.37% to -$5.4 million in 2026.
- Business Quant data shows VERU's Change in Cash at -$5.4 million in Q1 2026, $17.2 million in Q4 2025, and $784408.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - | -3.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.72 Mn |
| Mar 31, 2026 | -5.39 Mn |
| Dec 31, 2025 | 17.20 Mn |
| Sep 30, 2025 | 784,408.00 |
| Jun 30, 2025 | -5.01 Mn |
| Mar 31, 2025 | -6.59 Mn |
| Dec 31, 2024 | 1.69 Mn |
| Sep 30, 2024 | -4.23 Mn |
| Jun 30, 2024 | -5.59 Mn |
| Mar 31, 2024 | -5.84 Mn |
| Dec 31, 2023 | 30.95 Mn |
| Sep 30, 2023 | -6.59 Mn |
| Jun 30, 2023 | -7.29 Mn |
| Mar 31, 2023 | -23.43 Mn |
| Dec 31, 2022 | -33.26 Mn |
| Sep 30, 2022 | -20.36 Mn |
| Jun 30, 2022 | -11.46 Mn |
| Mar 31, 2022 | -4.09 Mn |
| Dec 31, 2021 | -6.26 Mn |
| Sep 30, 2021 | -796,433.00 |